58. 肥大型心筋症 Hypertrophic cardiomyopathy Clinical trials / Disease details

臨床試験数 : 119 / 薬物数 : 163 - (DrugBank : 45) / 標的遺伝子数 : 48 - 標的パスウェイ数 : 161

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR-IIR-17013661	2018-10-10	2017-12-03	Effect of beta-blockers combined with angiotensin II receptor blockers in regression of cardiac hype ...	Effect of beta-blockers combined with angiotensin II receptor blockers in regression of cardiac hype ...	Hypertrophic cardiomyopathy	Experimental group:MetoprololSuccinate Sustained-release Tablets combined with candesartantreatment; ...	The First Affiliated Hospital, Sun Yat-sen University	NULL	Recruiting	18	65	Both	Experimental group:130;Control group:130;	4 (Phase 4 study)	China
2	NCT00430833 (ClinicalTrials.gov)	March 2007	31/1/2007	CHANCE - Candesartan in Hypertrophic Cardiomyopathy	CandesartanUse in Hypertrophic and Non-Obstructive Cardiomyopathy Estate (The CHANCE): a Double-Blin ...	Hypertrophic Cardiomyopathy	Drug: candesartan	Charles University, Czech Republic	AstraZeneca	Active, not recruiting	18 Years	N/A	Both		Phase 2	Czech Republic

First Previous1Next Last